http://www.enterpriseeuropeni.com/inx/assets/images/sitelook/een.gif Fri, 3 Feb 2012 00:00:01 GMT Technology collaboration - 12 GB 47P8 3O0I OFFER

A drug discovery company (SME) based in North East of England wishes to offer its unique and world leading capabilities in natural product sourcing, genomics and target-based drug screening.SME also wishes to offer its exceptionally diverse collection of actinomycete bacteria, many of which are expected to produce bio-active molecules of different kinds against a range of high value targets, including drugs.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 GB 47P8 3O0I&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 GB 47P8 3O0I&EnquiryType=BBS Thu, 2 Feb 2012 00:00:02 GMT Technology collaboration - 11 DE 1377 3NBM OFFER

A German R&D institute has developed a novel dental prosthesis for high-precision and continous intraoral drug delivery. Its osmotic principle requires no electrical power. The cartridge is integrated into two buccal teeth of a removable partial denture. It was originally developed for the therapy of Parkinson patients. The R&D institute is now looking for industrial/academic partners for the transfer to drug delivery applications beyond Parkinson's Disease.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=11 DE 1377 3NBM&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=11 DE 1377 3NBM&EnquiryType=BBS Thu, 2 Feb 2012 00:00:03 GMT Technology collaboration - 12 TR 99PB 3O03 OFFER

A Turkish company specialized in the manufacturing of pathology and microbiology equipments developed a dispensing device for obtaining formalin in a given concentrate. This device can be used in every laboratory using formalin such as pathology, histology laboratories and it prevents the harmful effects of formalin to human health. The company is looking for commercial agreement with technical assistance to adapt the device to partners needs.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 TR 99PB 3O03&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 TR 99PB 3O03&EnquiryType=BBS Wed, 1 Feb 2012 00:00:04 GMT Technology collaboration - 12 HU 50S0 3NZ2 REQUEST

A Hungarian small enterprise is searching for a production line, with which it is possible to produce protein and/or sugar from vegetable basic commodities in a system connected to bio-gas works. The company is involved in projects dealing with bio-refinement, and it also possesses knowledge on agriculture and environment protection. The technology is ready for demonstration, or it can also appear on the market. Industrial companies can be partners.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 HU 50S0 3NZ2&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 HU 50S0 3NZ2&EnquiryType=BBS Tue, 31 Jan 2012 00:00:05 GMT Technology collaboration - 12 EE 21B9 3NVH OFFER

An Estonian SME has developed competences in HRM (High Resolution Melting) based genetic and epigenetic analyzing to medical and research laboratories. The method is fast, sensitive and cost-effective, enabling to detect specific variations even with relatively low incidence. Technical Cooperation or Commercial Agreement with Technical Assistance is sought.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 EE 21B9 3NVH&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 EE 21B9 3NVH&EnquiryType=BBS Tue, 31 Jan 2012 00:00:06 GMT Technology collaboration - 12 LU 87GA 3NZZ REQUEST

A large US company is looking for proposals for validated in vivo models able to link inhibition of autotoxin (ATX) activity and decline of lysophosphatidic acid (LPA) levels to the reduction of clinically relevant biomarkers, preferably, but not limited to oncology, immune-mediated diseases, or fibrosis. They are interested in contract research, joint development license agreement.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 LU 87GA 3NZZ&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 LU 87GA 3NZZ&EnquiryType=BBS Tue, 31 Jan 2012 00:00:07 GMT Technology collaboration - 12 LU 87GA 3O1W REQUEST

A large US company is looking for proposals for health measurement technology based on non-invasive collection and analysis of bio-fluid other than blood. Of interest are technologies for hand-held devices that are easy to use. They are interested in development contract, joint development, OEM/ODM.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 LU 87GA 3O1W&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 LU 87GA 3O1W&EnquiryType=BBS Fri, 27 Jan 2012 00:00:08 GMT Technology collaboration - 12 DE 1380 3O09 OFFER

A large German Research Institute has investigated and elucidated the effect of receptor-tyrosine kinase inhibitors which inhibit uncontrolled cell replications and other diseases caused by receptor-tyrosin kinase. This inhibitor is applicable in biotechnology or pharmaceutical industry. The institute seeks either a license agreement or a joint further development.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 DE 1380 3O09&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 DE 1380 3O09&EnquiryType=BBS Fri, 27 Jan 2012 00:00:09 GMT Technology collaboration - 12 ES 24D4 3O0Y OFFER

A Spanish university research group has developed a technology related to a process for the selection of neuronal cells in culture in terms of their differentiation, through the establishment of a dose-response relation by adding different concentrations of flubendiamide to several groups of nerve cells. Companies from agribusiness, chemical or pharmaceutical fields, and in antitumor or neuro-regenerative therapies, are sought for license agreements.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 24D4 3O0Y&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 24D4 3O0Y&EnquiryType=BBS Fri, 27 Jan 2012 00:00:10 GMT Technology collaboration - 12 FI 30I0 3NZJ OFFER

A Finnish research group has identified and isolated previously unknown CD117+ adult vascular endothelial stem cells (VESCs), which could be used in cell-based therapies to restore tissue vascularization in ischemic situation such as atherosclerosis and coronary artery disease. These cells are also the true biological target for all existing and future anti-angiogenic therapies. The researchers are looking for biotech or pharmaceutical companies for R&D partnership and out-licensing.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 FI 30I0 3NZJ&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 FI 30I0 3NZJ&EnquiryType=BBS Fri, 27 Jan 2012 00:00:11 GMT Technology collaboration - 12 IL 80EP 3O1C REQUEST

An Israeli clinical stage biotechnology company is looking for a partner to collaborate on developing its lead compound, a short peptide antagonist of CD28, for treatment of immune related diseases. The company is seeking to collaborate with service providers, academic researchers and clinical investigators in the fields of drug development (preclinical and clinical) in the area of Cardiovascular Ischemia reperfusion injury and multiple myeloma.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 IL 80EP 3O1C&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 IL 80EP 3O1C&EnquiryType=BBS Fri, 27 Jan 2012 00:00:12 GMT Technology collaboration - 12 IT 53U1 3O04 OFFER

A relevant Italian research centre has developed an innovative process of zeolite synthesis from fly ash at very low temperature by using seawater. The process represents a concrete potential application to obtain industrial products from waste material with economical advantages. The centre is looking for support in scientific research and in practical application. The partners sought are industries and research organisations in the field of: environmental monitoring; cement; nano-materials.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 IT 53U1 3O04&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 IT 53U1 3O04&EnquiryType=BBS Thu, 26 Jan 2012 00:00:13 GMT Technology collaboration - 12 ES 23D2 3NYW OFFER

A Spanish research group has developed a new generation of biomarkers based on magnetic and fluorescent properties. The hybrid bio-particles can be used for cell imaging and monitoring, drug delivery and biomarking according to specific requirements. The process is fully developed, patented and lab tests are available. The research group is looking for companies acquiring this technology for its exploitation, although it is open to other kind of collaboration.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 23D2 3NYW&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 23D2 3NYW&EnquiryType=BBS Wed, 25 Jan 2012 00:00:14 GMT Technology collaboration - 12 ES 27F4 3NXY OFFER

An Andalucian research group has developed and patented a technology for obtaining animal cell lines resistant to cytotoxic drugs that act by inhibiting the vacuolar ATPase. These cell lines may be the basis for restoring tissues and organs damaged by chemotherapy. Industrial partners interested in a patent license for the exploitation of the technology are sought.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 27F4 3NXY&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 27F4 3NXY&EnquiryType=BBS Wed, 25 Jan 2012 00:00:15 GMT Technology collaboration - 12 ES 28G2 3NY3 OFFER

A Spanish public research organisation has devised a minimal system for in vitro terminal protein (TP)-primed amplification of lineal DNA. A 69-194 nucleotide sequence of the phage Phi29 DNA is attached to each end of the lineal DNA and high fidelity DNA copies, linked to TP are synthesized by adding Phi29 TP, DNA polymerase and two DNA binding proteins. Besides, TP-DNA is itself useful for protein-DNA applications. They look for biotechs to sell DNA-amplification kits under a patent licence.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 28G2 3NY3&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 28G2 3NY3&EnquiryType=BBS Tue, 24 Jan 2012 00:00:16 GMT Technology collaboration - 12 DE 1486 3NWJ OFFER

A technology transfer office in Bavaria represents a known German university. Its Institute of Molecular Virology focuses on intracellular signal transduction pathways and their impact on viral infection and inflammation. The investigators could show that the attenuation of influenza A viruses (IAV) by introduction of silent mutations into the nucleoprotein (NP) gene may serve as a strategy for a live attenuated vaccine. We are looking for a licensee.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 DE 1486 3NWJ&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 DE 1486 3NWJ&EnquiryType=BBS Mon, 23 Jan 2012 00:00:17 GMT Technology collaboration - 12 ES 28G2 3NW2 OFFER

A Spanish public research organisation has developed a potential treatment for Niemann-Pick type A disease, a rare hereditary illness with no cure, in which sphingomyelin builds up due to a lack of acid sphyngomyelinase. Their researchers have stimulated neutral sphingomyelinase with vitamin D or dexamethasone, achieving an in vitro decrease of 34% and 46% in cellular sphingomyelin, respectively. Companies interested in R+D collaboration and/or patent licensing are sought for.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 28G2 3NW2&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 28G2 3NW2&EnquiryType=BBS Fri, 20 Jan 2012 00:00:18 GMT Technology collaboration - 12 ES 28G2 3NVT OFFER

A Spanish public research organisation has synthesized quinoline derivatives inhibiting allosterically and reversibly the enzyme GSK-3 at micromolar levels. These inhibitors minimize the appearance of side effects and drug resistance as they are more selective than conventional inhibitors. These are excellent drug candidates for neurodegenerative and inflammatory diseases, cancer, diabetes, and regenerative processes. Pharmaceutical companies interested in a patent licence are sought for.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 28G2 3NVT&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 28G2 3NVT&EnquiryType=BBS Thu, 19 Jan 2012 00:00:19 GMT Technology collaboration - 12 HU 5010 3NV9 OFFER

A leading biotechnology SME in Hungary, offers the ability to create transgenic rabbit and rat models via microinjecting large genomic fragments at its state-of-the-art facility. Proven track record with some of the world's leading developers of rabbit and rat models. The technology ensures high level tissue and developmental stage specific expression of the transgene. Pharma manufacturers and R&D partners are sought for technical cooperation, commercial or manufacturing agreements.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 HU 5010 3NV9&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 HU 5010 3NV9&EnquiryType=BBS Tue, 17 Jan 2012 00:00:20 GMT Technology collaboration - 11 FR 33j6 3NL4 OFFER

An academic French laboratory has patented a new antiviral treatment against human rhinovirus and enterovirus. This treatment is based on peptides that inhibit replicative viral cycle. It can be used for various diseases such as common cold, acute otisis media and sinusitis. Industrial partners are sought for technical cooperation and/or licence agreement.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=11 FR 33j6 3NL4&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=11 FR 33j6 3NL4&EnquiryType=BBS Tue, 17 Jan 2012 00:00:21 GMT Technology collaboration - 12 ES 27F4 3NXT OFFER

The leucine-rich repeat kinase 2 (LRRK2) is a potential therapeutic target for Parkinson's disease. A Spanish public research organisation has designed a faster and more reliable method to identify inhibitors of LRRK2 and related targets (such as the lysosomal two-pore channel) by determining, in cell cultures, autophagy rate, lysosomal pH, and cell death when adding proteosome inhibitors. Pharmaceutical companies or manufacturers of research reagents are offered a patent licence.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 27F4 3NXT&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 27F4 3NXT&EnquiryType=BBS Fri, 13 Jan 2012 00:00:22 GMT Technology collaboration - 12 ES 28G2 3NU2 OFFER

A Spanish public research organisation has synthesized cyclohexane epoxides and aziridines, structurally related to galactose, that act as irreversible inhibitors of a-galactosidases and b-galactosidases at micro- and nanomolar concentrations. These compounds may have application as pharmacological tools for structural and functional elucidation of this type of enzymes, and as drugs in the treatment of diseases related with their dysfunction. Biotech partners are sought under a patent licence.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 28G2 3NU2&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 ES 28G2 3NU2&EnquiryType=BBS Thu, 12 Jan 2012 00:00:23 GMT Technology collaboration - 11 DE 0855 3NQJ OFFER

Researchers from a German university offer a segmented flow biofilm reactor wherein a biofilm can be grown and maintained for performing a biotransformation reaction or fermentation in the presence of a segmented flow. The invention further concerns a method for transforming a substrate to a product in the presence of a segmented flow. Innovative companies from different industries (biotech, pharma, chemical engineering etc.) are sought for licensing agreements and/or research collaboration.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=11 DE 0855 3NQJ&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=11 DE 0855 3NQJ&EnquiryType=BBS Thu, 12 Jan 2012 00:00:24 GMT Technology collaboration - 11 DE 0855 3NRB OFFER

A German university offers a cost-efficient technology which uses a fungal host as novel cellular platform for economically interesting protein production. Even the production of large proteins, e.g.single-chain antibodies, that are difficult to obtain in standard expression systems, is possible. The method avoids post-translational modifications. They look for industrial partners which are active in the field of biotech, pharma or renewable resources for licencing or further co-development.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=11 DE 0855 3NRB&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=11 DE 0855 3NRB&EnquiryType=BBS Thu, 12 Jan 2012 00:00:25 GMT Technology collaboration - 12 BE 0213 3NUI REQUEST

The Brussels office of a young innovative company is looking for experts in the field of Eco-Design, Toxicology and Nanomaterials, in order to develop a cross-disciplinary database on advanced materials. The idea is to collect data about the toxicological impact and the Life Cycle Assessment (LCA) of advanced materials, for instance nanomaterials, along the supply chain. The aim is to develop collaborative research projects and apply for national or european fundings.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 BE 0213 3NUI&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=300&id=12 BE 0213 3NUI&EnquiryType=BBS